rs606231409
Variant summary
Our verdict is Pathogenic. Variant got 12 ACMG points: 12P and 0B. PVS1PM2PP5_Moderate
The NM_000216.4(ANOS1):c.1A>T(p.Met1?) variant causes a initiator codon change involving the alteration of a non-conserved nucleotide. The variant was absent in control chromosomes in GnomAD project. In-silico tool predicts a pathogenic outcome for this variant. Variant has been reported in ClinVar as Pathogenic (★).
Frequency
Consequence
NM_000216.4 initiator_codon
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Pathogenic. Variant got 12 ACMG points.
Transcripts
RefSeq
Ensembl
Frequencies
GnomAD3 genomes Cov.: 24
GnomAD4 exome Cov.: 30
GnomAD4 genome Cov.: 24
ClinVar
Submissions by phenotype
Hypogonadotropic hypogonadism 1 with or without anosmia Pathogenic:1
Although this variant is expected to disrupt protein translation of the ANOS1 mRNA, experimental studies have not been reported for this variant. It is currently unknown how this variant will affect protein function. This sequence change affects the initiator methionine of the ANOS1 mRNA. While this variant is not present in population databases, the frequency information is unreliable, as metrics indicate poor data quality at this position in the ExAC database. This variant has been observed in individuals with clinical features consistent with ANOS1-related disease (Invitae). However, the variant has not been reported in the literature. Two other initiator methionine variants (c.1A>G and c.3G>A) have been reported in multiple individuals with idiopathic hypogonadotropic hypogonadism and anosmia from two different families (PMID: 15605412, 26708526), indicating that disruption of the initiator codon for ANOS1 is pathogenic. For these reasons, this variant has been classified as Pathogenic. -
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at